About Technology Issues FAQ

Links

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.